Genome Surgery & Neuronal Disorders

Genome surgery using CRISPR genomic techniques offer the potential to correct disease-causing mutations in many neuronal disorders. Here are the latest discoveries pertaining to genome surgery and neuronal disorders.

June 20, 2020
Review
Open Access

Advancing gene therapies, methods, and technologies for Parkinson's Disease and other neurological disorders

Neurologia i neurochirurgia polska
Massimo S FiandacaKrystof S Bankiewicz
July 22, 2020
Open Access

Metamizole relieves pain by influencing cytokine levels in dorsal root ganglia in a rat model of neuropathic pain

Pharmacological Reports : PR
Renata ZajaczkowskaJoanna Mika
September 8, 2020
Open Access

Neuronal intranuclear inclusion disease (NIID)

Rinshō shinkeigaku = Clinical neurology
Jun Sone
August 8, 2020
Review
Open Access

Innovative Therapeutic and Delivery Approaches Using Nanotechnology to Correct Splicing Defects Underlying Disease

Frontiers in Genetics
Marc Suñé-PouCarlos Suñé
September 12, 2020
Review

Direct convective delivery of adeno-associated virus gene therapy for treatment of neurological disorders

Journal of Neurosurgery
Russell R LonserKrystof S Bankiewicz
July 9, 2020
Review

Modern approaches in gene therapy of motor neuron diseases

Medicinal Research Reviews
Maria Zakharova
August 14, 2020
Review
Open Access

Recent developments in the treatment of Parkinson's Disease

F1000Research
Thomas B Stoker, Roger A Barker
July 3, 2020

Impact of multiple sclerosis risk loci in postinfectious neurological syndromes

Multiple Sclerosis and Related Disorders
Filippo Martinelli-BoneschiEnrico Marchioni
June 27, 2020
Review
Open Access

Klotho and the Treatment of Human Malignancies

Cancers
Aishani SachdevaIrene Chong
July 9, 2020
Open Access

A Mixed-Surface Polyamidoamine Dendrimer for In Vitro and In Vivo Delivery of Large Plasmids

Pharmaceutics
Bhairavi SrinageshwarJulien Rossignol
September 11, 2020

Emerging Therapies in Friedreich's Ataxia

Expert Review of Neurotherapeutics
Theresa A ZesiewiczJoshua Vega
June 23, 2020
Case Report

A new paraplegin mutation in a patient with primary progressive multiple sclerosis

Multiple Sclerosis and Related Disorders
Angelo BellinviaSabrina Matà
August 9, 2020
Case Report
Open Access

Case Report: Early Treatment With Chenodeoxycholic Acid in Cerebrotendinous Xanthomatosis Presenting as Neonatal Cholestasis

Frontiers in Pediatrics
Irene DegrassiGabriella Nebbia
July 10, 2020
Open Access

Insulin-like growth factor 2 (IGF2) protects against Huntington's disease through the extracellular disposal of protein aggregates

Acta Neuropathologica
Paula García-HuertaClaudio Hetz

Sign up to follow this feed and discover related papers.

Related Feeds

ALS

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

Acute Myeloid Leukaemia & RNA

Acute myeloid leukaemia (AML) is a common hematological type of cancer. As the population ages, there has been a rise in the frequency of AML. RNA expression has been used to see if there are different genetic profiles that exist within AML and whether these may underpin the variations in survival rates. Here is the latest research on AML and RNA.

© 2020 Meta ULC. All rights reserved
/feed-previews/genome-surgery-neuronal-disorders/46af9a03-6bab-45f4-a4c4-2f46679f9852